Export 148 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
C. Gurgol, Foley, A., Belt, P., Denzen, E., Duffy, S., Gallagher, C., Grodman, C., Horowitz, M., Confer, D., and Carter, S., “Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster).”, in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
A. Guimarães-Walker, Mackie, N., McMichael, A., Weber, J., McCormack, S., Cebere, I., Kay, R., Hanke, T., Dally, L., Gibiansky, L., Legg, K., DeSouza, C., Hayes, P., Gilmour, J., and Fast, P., “Priming with a candidate HIV-1 clade A DNA vaccine followed by boosting with an HIV-1 Clade A MVA vaccine in volunteers at low risk of HIV infection”, 2004.
A. Guimarães-Walker, Mackie, N., McCormack, S., Hanke, T., Schmidt, C., Gilmour, J., Barin, B., McMichael, A., Weber, J., Legg, K., Babiker, A., Hayes, P., Gotch, F., Smith, C., Dally, L., Dorrell, L., Cebere, I., Kay, R., Winstone, N., Moore, S., Goonetilleke, N., and Fast, P., “Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.”, Vaccine, vol. 26, no. 51, pp. 6671-7, 2008.
D. Gu, Mao, Y., Tang, Z., Montaner, J., Shen, Z., Zhu, Q., Detels, R., Jin, X., Xiong, R., Xu, J., Ling, W., Erinoff, L., Lindblad, R., Liu, D., Van Veldhuisen, P., Hasson, A., and Wu, Z., “Loss to Follow-Up from HIV Screening to ART Initiation in Rural China.”, PLoS One, vol. 11, no. 10, p. e0164346, 2016.
J. Gryczynski, McNeely, J., Wu, L. - T., Subramaniam, G. A., Svikis, D. S., Cathers, L. A., Sharma, G., King, J., Jelstrom, E., Nordeck, C. D., Sharma, A., Mitchell, S. G., O'Grady, K. E., and Schwartz, R. P., “Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.”, J Gen Intern Med, vol. 32, no. 9, pp. 990-996, 2017.
T. S. S. R. Group., “SCORE Study Report 5: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid f”, Archives of Ophthalmology, vol. 127, pp. 1101-1114, 2009.
“Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes.”, Transplantation, vol. 72, no. 3, pp. 463-76, 2001.
A. - R. Eye Diseas Group, “A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Age-Related Eye Disease Study Report No. 8”, Archives of Ophthalmology, vol. 119, pp. 1417-1436, 2001.
T. S. T. O. P. - R. O. P. M. Group, “Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes”, Pediatrics, vol. 105, pp. 295-310, 2000.
T. A. R. E. D. S. 2- H. O. M. Group, Chew, W. C., Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., and Garfinkel, R., “Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study”, Ophthalmology, vol. 121, pp. 535-534, 2014.
T. Age- Relate Group, Chew, E. Y., Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., Sperduto, R., and Ferris, F. L., “The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report No. 1)”, Ophthalmology, vol. 119, pp. 2282-2289, 2012.
“The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants--Age-Related Eye Disease Study Report No. 2.”, J Nutr, vol. 130, no. 5S Suppl, p. 1516S-9S, 2000.
theC. R. A. F. Study Group, “Prograf as secondary intervention vs continuation of cyclosporine in patients at risk for chronic renal allograft failure (CRAF) results in improved renal function, decreased CV risk, and no increased risk for diabetes”, 2003.
A. - R. Eye Diseas Group, “The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS Report No. 4”, Am J Ophthalmol, vol. 131, pp. 167-75, 2001.
S. P. L. I. T. Research Group, “Waiting list mortality for pediatric patients with chronic liver disease.”, 1998.
“The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.”, Control Clin Trials, vol. 20, no. 6, pp. 573-600, 1999.
A. - R. Eye Diseas Group, “AREDS Update I: The effect of cataract surgery on progression to advanced AMD”, 2003.
“The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7.”, J Nutr, vol. 132, no. 4, pp. 697-702, 2002.
E. Y. Chew, Clemons, T. E., Sangiovanni, J. Paul, Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., Fish, G. E., Hubbard, G. Baker, Klein, M. L., Chandra, S. R., Blodi, B. A., Domalpally, A., Friberg, T., Wong, W. T., Rosenfeld, P. J., Agrón, E., Toth, C. A., Bernstein, P. S., and Sperduto, R. D., “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
A. - R. Eye Diseas Group, SanGiovanni, J. P., Chew, E., Clemons, T., III, F. L. Ferris, Gensler, G., Lindblad, A. S., Milton, R., Seddon, J. M., and Sperduto, R., “The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22”, Arch Ophthalmol, vol. 125, pp. 1225-1232, 2007.
A. - R. Eye Diseas Group, “Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report No. 3”, Ophthalmology, vol. 107, pp. 2224-32, 2000.
A. - R. Eye Diseas Group, “AREDS extension of the Wisconsin age-related maculopathy grading system”, 1998.
A. - R. Eye Diseas Group, “Impact of antioxidants, zinc, and copper on cognition in the elderly. A randomized, controlled trial. AREDS Report No. 12”, Neurology, vol. 63, pp. 1705-1707, 2004.
J. Paul Sangiovanni, Chew, E. Y., Clemons, T. E., Ferris, F. L., Gensler, G., Lindblad, A. S., Milton, R. C., Seddon, J. M., and Sperduto, R. D., “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.”, Arch Ophthalmol, vol. 125, no. 9, pp. 1225-32, 2007.
A. - R. Eye Diseas Group, “National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 10”, Arch Ophthalmol, vol. 121, pp. 211-217, 2003.